Prevention and Resolution of Silicone Implant-Related Problems in Secondary Rhinoplasty Using a Cross-Linked Human...

Area of Science:

• Plastic Surgery
• Regenerative Medicine
• Facial Reconstructive Surgery

Background:

• Revision rhinoplasty is frequently needed after silicone implant augmentation in Asian patients.
• Previous revision techniques using silicone, dermofat, or cartilage often yield unsatisfactory results.
• This study evaluates cross-linked acellular dermal matrix (ADM) as a biological alternative to silicone for secondary rhinoplasty.

Purpose of the Study:

• To assess the surgical outcomes and complications of using cross-linked acellular dermal matrix (ADM) in secondary rhinoplasty.
• To compare ADM's efficacy against traditional grafting materials for revision rhinoplasty.
• To evaluate patient-reported outcomes using the modified Rhinoplasty Outcome Evaluation (ROE).

Main Methods:

• Prospective study of 56 patients undergoing secondary rhinoplasty with a minimum 1-year follow-up.
• Procedures included silicone implant removal and dorsal augmentation with ADM, alongside autogenous cartilage tip plasty.
• Patient outcomes were assessed using the modified ROE questionnaire preoperatively and at 6 months and 1 year postoperatively.

Main Results:

• One infection and three cases of excessive resorption were observed; no other major complications occurred.
• Mean modified ROE scores significantly improved from 31.7 preoperatively to 77.3 at 6 months and 81.4 at 1 year (P < 0.001).
• Favorable outcomes included contracture deformity resolution, firm implant fixation, and improved aesthetic contour.

Conclusions:

• Cross-linked human ADM is a successful alternative to silicone for secondary rhinoplasty, effectively resolving deformities.
• ADM offers a low infection rate, good implant stability, and satisfactory aesthetic results in revision cases.
• ADM provides a viable biological substitute for silicone, enhancing patient satisfaction in revision rhinoplasty.